After-Hours Movers: Salesforce Gains on Strong LT Guidance, KB Home Falls Post EPS
- Wall St slumps as investors fret on rate hikes and recession
- Think September Was Bad? Watch Out for 'Octoberphobia', Stock Trader's Almanac Warns
- Goldman Sachs Slashes Year-End Target on S&P 500 to 3,600
- Oil: The 'R'-Word Rules as U.S. Crude Below $80 for Worst Week in 7
- Bond Crash of 2022 is a 'Doozy' - BofA
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
After-Hours Stock Movers:
DBV Technologies (Nasdaq: DBVT) INDICATED 20%+ LOWER; announced that it received feedback from the U.S. Food and Drug Administration (FDA) in the form of a partial clinical hold on its VITESSE (Viaskin Peanut Immunotherapy Trial to Evaluate Safety, Simplicity and Efficacy) Phase 3 clinical study.
H.B. Fuller (NYSE: FUL) 3% HIGHER; reported Q3 EPS of $1.06, $0.01 better than the analyst estimate of $1.05. Revenue for the quarter came in at $941.2 million versus the consensus estimate of $945.1 million. H.B. Fuller sees Q4 2022 EPS of $1.15-$1.30, versus the consensus of $1.28
TOP Ships Inc. (NASDAQ: TOPS) 3% LOWER; determined to effect a 1-for-20 reverse stock split of the Company's issued common shares.
KB Home (NYSE: KBH) 2% LOWER; reported Q3 EPS of $2.86, $0.20 better than the analyst estimate of $2.66. Revenue for the quarter came in at $1.84 billion versus the consensus estimate of $1.88 billion. Sees Q4 Housing revenues in the range of $1.95 billion to $2.05 billion.
Salesforce (NYSE: CRM) 2% HIGHER; targets $50 billion in revenue in FY26, representing 17% CAGR
Lennar Corp. (NYSE: LEN) 1% HIGHER; reported Q3 EPS of $5.18, $0.32 better than the analyst estimate of $4.86. Revenue for the quarter came in at $8.9 billion versus the consensus estimate of $8.97 billion.
Prudential Financial (NYSE: PRU) 1% HIGHER; Raymond James initiates coverage with a Strong Buy rating and a price target of $115.00.
Trip.com Group (NASDAQ: TCOM) 1% HIGHER; reported Q2 EPS of (RMB0.31), RMB0.46 worse than the analyst estimate of RMB0.15. Revenue for the quarter came in at RMB4 billion versus the consensus estimate of RMB3.58 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on EPS
- AEON Biopharma Reports Positive Topline Results from Phase 2 Clinical Trial of ABP-450 (prabotulinumtoxinA) in Cervical Dystonia
- Companies with NDRs 9/22
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesRaymond James, After-Hours Movers, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!